Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer ; volume:29 ; number:03 ; year:2008 ; pages:7-10
Indian journal of medical & paediatric oncology ; 29, Heft 03 (2008), 7-10
- Beteiligte Personen und Organisationen
-
Ghosh, Jaya
Kumar, Lalit
- DOI
-
10.4103/0971-5851.51414
- URN
-
urn:nbn:de:101:1-2022042810022210418278
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ghosh, Jaya
- Kumar, Lalit
Ähnliche Objekte (12)
Surgery for Recurrent Epithelial Ovarian Cancer
Treatment of Recurrent Epithelial Ovarian Cancer
Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
Bevacizumab for patients with recurrent multifocal glioblastomas
Predicting prognosis for epithelial ovarian cancer patients receiving bevacizumab treatment with CT-based deep learning
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study
Therapy for Recurrent High-Grade Epithelial Ovarian Cancer—The Current Status and Future Trends
Surgery in recurrent ovarian cancer
Surgery for Recurrent Epithelial Ovarian Cancer
Treatment of Recurrent Epithelial Ovarian Cancer
Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
Bevacizumab for patients with recurrent multifocal glioblastomas
Predicting prognosis for epithelial ovarian cancer patients receiving bevacizumab treatment with CT-based deep learning
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study
Therapy for Recurrent High-Grade Epithelial Ovarian Cancer—The Current Status and Future Trends
Surgery in recurrent ovarian cancer
Surgery for Recurrent Epithelial Ovarian Cancer
Treatment of Recurrent Epithelial Ovarian Cancer
Austria-based real-world data on bevacizumab in newly diagnosed epithelial ovarian cancer
Economic Evaluation of Bevacizumab for Treatment of Platinum-Resistant Recurrent Ovarian Cancer in Canada
Bevacizumab for patients with recurrent multifocal glioblastomas
Predicting prognosis for epithelial ovarian cancer patients receiving bevacizumab treatment with CT-based deep learning
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer
Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study
Therapy for Recurrent High-Grade Epithelial Ovarian Cancer—The Current Status and Future Trends